„Development of
Mathematical
Models of Novel HPV-Based Cervical Cancer Screening Protocols for
Evaluation
of the Projected Health and Cost Benefits (HPVCCS)”
The European Cervical Cancer
Consortium has been funded by the European Commission to undertake
cost-benefit
modelling of cervical cancer screening protocols based on new
technologies,
such as testing for the Human papillomavirus (HPV).
The objective of the project
is to develop mathematical models of HPV/cytology based cervical cancer
screening protocols for the evaluation of the health and cost benefits
for EU states. The long-term performance of a combined HPV/cytology
regimen
on a country-specific basis is established from screening trials that
are
running in 6 different European countries and combined at a European
level.
In addition the costs of existing cervical cancer screening programs
and
related healthcare actions are collected. These data will be combined
in
mathematical models used to evaluate clinical outcomes and healthcare
cost
benefits for different scenarios. The outcome of this analysis will be
used to develop interim, fully costed, country- and EU-specific
cervical
cancer screening protocols, which will be used to start an informed
debate
leading to the development of a new European consensus policy for
screening
of cervical cancer.
